In pediatric peritoneal dialysis patients, treatment with calcium carbonate or sevelamer resulted in equivalent control of phosphate, PTH and skeletal changes of secondary hyperparathyroidism. This evidence concerns the gene PTH and secondary hyperparathyroidism.